|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0011209,
umls-concept:C0025914,
umls-concept:C0026809,
umls-concept:C0033684,
umls-concept:C0205314,
umls-concept:C0242350,
umls-concept:C0302350,
umls-concept:C0332307,
umls-concept:C0533670,
umls-concept:C0679199,
umls-concept:C0679622,
umls-concept:C1298998,
umls-concept:C1512919,
umls-concept:C1883254
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2010-11-2
|
|
pubmed:abstractText |
Patients with erectile dysfunction (ED) associated with type II diabetes often have impaired endothelial function and tend to respond poorly to oral phosphodiesterase type 5 inhibitors. Therefore, neovascularization is a promising strategy for curing diabetic ED.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1743-6109
|
|
pubmed:author |
pubmed-author:ChoiMin JiMJ,
pubmed-author:JinHai-RongHR,
pubmed-author:KimWoo JeanWJ,
pubmed-author:KohGou YoungGY,
pubmed-author:KwonMi-HyeMH,
pubmed-author:PiaoShuguangS,
pubmed-author:RyuJi-KanJK,
pubmed-author:ShinSun HwaSH,
pubmed-author:SongJae SookJS,
pubmed-author:SongKang-MoonKM,
pubmed-author:SuhJun-KyuJK,
pubmed-author:TumurbaatarMunkhbayarM,
pubmed-author:TuvshinturBuyankhuuB,
pubmed-author:YinGuo NanGN
|
|
pubmed:copyrightInfo |
© 2010 International Society for Sexual Medicine.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
7
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3635-46
|
|
pubmed:meshHeading |
pubmed-meshheading:20584113-Angiopoietin-1,
pubmed-meshheading:20584113-Animals,
pubmed-meshheading:20584113-Antigens, CD31,
pubmed-meshheading:20584113-Apoptosis,
pubmed-meshheading:20584113-Cyclic AMP,
pubmed-meshheading:20584113-Cyclic GMP,
pubmed-meshheading:20584113-Diabetes Mellitus, Type 2,
pubmed-meshheading:20584113-Endothelium, Vascular,
pubmed-meshheading:20584113-Erectile Dysfunction,
pubmed-meshheading:20584113-Male,
pubmed-meshheading:20584113-Mice,
pubmed-meshheading:20584113-Nitric Oxide Synthase Type III,
pubmed-meshheading:20584113-Penile Erection,
pubmed-meshheading:20584113-Penis,
pubmed-meshheading:20584113-Phosphodiesterase 5 Inhibitors,
pubmed-meshheading:20584113-Recombinant Proteins
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Intracavernous delivery of synthetic angiopoietin-1 protein as a novel therapeutic strategy for erectile dysfunction in the type II diabetic db/db mouse.
|
|
pubmed:affiliation |
National Research Laboratory of Regenerative Sexual Medicine and Department of Urology, Inha University School of Medicine, Incheon, Korea.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
